retroviral-mediated transfer of iduronate-2-sulfatase gene into lymphocytes
Gene therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 1996 (NCT00004454)
Timeline
1990s
- Jan 1, 1996
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, passive
immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- retroviral-mediated transfer of iduronate-2-sulfatase gene into lymphocytes
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004454 | Phase 1/Phase 2 (Phase 2) | Oct 1, 1996 | National Institutes of Health (NIH), University of Minnesota |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institutes of Health (NIH) | Government | 1 | 1 | 1 | 1996 |
| University of Minnesota | Academic/Hospital | 1 | 0 | 1 | 1996 |
2 organizations
Page 1 / 1